FDA staff report says data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults

Hits: 26

FDA staff said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.  Read More Go To Source

Be the first to comment

Leave a Reply

Your email address will not be published.


eleven − 7 =